$407.29
+4.99 (+1.24%)
At Close: Jun 03, 2026
Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today
06:51pm, Friday, 13'th Mar 2026
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $472.16, denoting a -1.48% move from the preceding trading day.
Wall Street Analysts Think Intuitive Surgical (ISRG) Could Surge 29.72%: Read This Before Placing a Bet
10:55am, Friday, 13'th Mar 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Intuitive Surgical (ISRG). While the effectiveness of this highly sought-after metric is questionable,
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
10:00am, Friday, 13'th Mar 2026
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
07:01pm, Thursday, 12'th Mar 2026
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $479.27, marking a -2.76% move from the previous day.
ISRG's da Vinci Gains FDA Nod for Cardiac Surgery: TAM Growth Ahead?
01:21pm, Thursday, 12'th Mar 2026
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.
Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
02:45am, Thursday, 12'th Mar 2026
Intuitive Surgical is initiated with a Buy rating and a $584.87 price target, reflecting 19% upside potential. ISRG's business model benefits from robust recurring revenues in consumables and services
Intuitive Surgical Stock: Buy, Sell, or Hold?
12:03am, Thursday, 12'th Mar 2026
Intuitive Surgical's fourth-quarter revenue increased 19% year over year. Management guided for a notable deceleration in worldwide da Vinci procedure growth in 2026.
Intuitive Surgical - Strong Moat But Valuation Remains Elevated, Hold
11:57am, Wednesday, 11'th Mar 2026
Intuitive Surgical (ISRG) remains the robotic-assisted surgery market leader, with Q4 procedures up 18% and revenue rising 19% to $2.87 billion. ISRG's recurring revenue model, high margins, and $3B n
Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott
10:25am, Wednesday, 11'th Mar 2026
Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector's fundamentals remain intact, even as broader market volatility has dragged down some o
Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
09:25am, Wednesday, 11'th Mar 2026
ISRG rides da Vinci 5 momentum as procedure volumes surge, global adoption expands and Ion and SP platforms boost recurring revenue growth into 2026.
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn't see the snapback rally that was the star of the show Monday, at least all four majo
2 Growth Stocks to Hold for the Next Decade
03:27pm, Tuesday, 10'th Mar 2026
Intuitive Surgical is plenty able to navigate its current issues while capitalizing on growing demand for its devices. DexCom's total installed base is a fraction of its addressable market, giving it
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
10:36am, Tuesday, 10'th Mar 2026
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?
10:30am, Monday, 09'th Mar 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Aptus Capital Advisors LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG
03:54am, Friday, 06'th Mar 2026
Aptus Capital Advisors LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 8.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities
Sign In
Buy ISRG